| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 59.635 | 43.881 | 43.871 | 51.323 | 35.167 | 3.126 | 25.141 | 3.247 | 8.854 | 16.390 |
| Total Income - EUR | 61.731 | 43.881 | 43.871 | 66.113 | 35.240 | 3.126 | 25.155 | 3.247 | 8.855 | 16.398 |
| Total Expenses - EUR | 43.252 | 36.087 | 29.039 | 66.032 | 25.292 | 8.097 | 15.594 | 6.364 | 37.797 | 9.674 |
| Gross Profit/Loss - EUR | 18.480 | 7.795 | 14.832 | 82 | 9.948 | -4.971 | 9.561 | -3.116 | -28.942 | 6.724 |
| Net Profit/Loss - EUR | 16.628 | 7.129 | 9.578 | -580 | 9.344 | -5.058 | 8.807 | -3.214 | -29.002 | 5.617 |
| Employees | 4 | 3 | 3 | 4 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Sara Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 52.594 | 46.214 | 39.814 | 6.613 | 2.371 | 1.192 | 868 | 572 | 273 | 0 |
| Current Assets | 42.312 | 46.320 | 52.260 | 64.692 | 71.622 | 62.346 | 71.090 | 53.255 | 17.349 | 15.785 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 6.004 | 6.939 | 7.920 | 8.471 | 9.858 | 9.671 | 20.388 | 10.094 | 10.085 | 10.116 |
| Cash | 36.308 | 39.381 | 44.340 | 56.221 | 61.764 | 52.675 | 50.701 | 43.161 | 7.264 | 5.669 |
| Shareholders Funds | -15.998 | -8.706 | 1.019 | 421 | 9.757 | 4.514 | 8.855 | -3.165 | -32.157 | -39.895 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 110.904 | 101.240 | 91.055 | 70.884 | 64.236 | 59.025 | 63.102 | 56.992 | 49.779 | 55.681 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Sara Medica Srl